Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

With COVID cases on the rise in many countries, the race to find an effective vaccine is becoming a more pressing concern ...

The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

While Australia's therapeutic goods regulator is evaluating two new vaccines targeting the JN.1 strain of COVID-19, the ...

Pfizer and BioNTech said on Friday that a committee from the European Medicine Agency recommended marketing authorization for its Omicron adapted vaccine to prevent Covid-19, meaning the vaccine is ...

These extra doses will bring more highly specialised work making these novel molecules to contract manufacturing ...

Flu season approaches and there's a new COVID variant. The time to act is now, or soon, according to the two largest local ...

Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...

If you’ve received the COVID-19 vaccine, you may have experienced common side effects such as pain, fatigue, or fever, or ...

A summer wave of cases locally and across the country may be on the decline and a vaccine targeting the latest variants is ...

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...